The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function.
D
D
Iyú
J R
JR
Glenn
A E
AE
White
A
A
Johnson
S
S
Heptinstall
S C
SC
Fox
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000378:metabolism; D050197:Atherosclerosis / Q000378:metabolism; D001792:Blood Platelets / Q000166:cytology* / Q000378:metabolism; D002319:Cardiovascular System; D004305:Dose-Response Relationship, Drug; D006801:Humans; D019007:P-Selectin / Q000096:biosynthesis; D010972:Platelet Activating Factor / Q000378:metabolism; D010974:Platelet Aggregation; D018078:Receptors, Prostaglandin E / Q000378:metabolism*
D019007:P-Selectin; D010972:Platelet Activating Factor; D018078:Receptors, Prostaglandin E; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; C033246:prostaglandin E3; D000527:Alprostadil